Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ralph Corey

Showing results (61-70 of 157) with videos related to

Pageof 16
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in AdultsThomas L Holland, Henry F Chambers, Helen W Boucher, et al.
American Heart Journal|April 13, 2004
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999Christopher H Cabell, Paul A Heidenreich, Vivian H Chu, et al.
Clinical Therapeutics|July 31, 2017
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive PathogensDavid B Huang, Thomas M File, Antoni Torres, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
<i>In Vitro</i> Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017Ian Morrissey, Stephen Hawser, Sibylle H Lob, et al.
Pediatrics|December 17, 2004
Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremiaAnne Marie Valente, Rajiv Jain, Mark Scheurer, et al.
BMJ (Clinical Research Ed.)|May 5, 2011
Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after studyMartin H Thornhill, Mark J Dayer, Jamie M Forde, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureusEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Perioperative Medicine (London, England)|June 18, 2016
A randomized, double-blind, placebo controlled safety, tolerability, and pharmacokinetic dose escalation study of a gentamicin vancomycin gel in patients undergoing colorectal surgeryElliott Bennett-Guerrero, Harold S Minkowitz, Alvaro M Segura-Vasi, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 6, 2007
Correlation between fundamental binding forces and clinical prognosis of Staphylococcus aureus infections of medical implantsRuchirej Yongsunthon, Vance G Fowler, Brian H Lower, et al.
Current Infectious Disease Reports|July 10, 2007
Medical treatment of endocarditisElias Abrutyn, Christopher H Cabell, Vance G Fowler, et al.
Pageof 16

Showing results (61-70 of 157) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in AdultsThomas L Holland, Henry F Chambers, Helen W Boucher, et al.
American Heart Journal|April 13, 2004
Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999Christopher H Cabell, Paul A Heidenreich, Vivian H Chu, et al.
Clinical Therapeutics|July 31, 2017
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive PathogensDavid B Huang, Thomas M File, Antoni Torres, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
<i>In Vitro</i> Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017Ian Morrissey, Stephen Hawser, Sibylle H Lob, et al.
Pediatrics|December 17, 2004
Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremiaAnne Marie Valente, Rajiv Jain, Mark Scheurer, et al.
BMJ (Clinical Research Ed.)|May 5, 2011
Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after studyMartin H Thornhill, Mark J Dayer, Jamie M Forde, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureusEsteban C Nannini, Martin E Stryjewski, Kavindra V Singh, et al.
Perioperative Medicine (London, England)|June 18, 2016
A randomized, double-blind, placebo controlled safety, tolerability, and pharmacokinetic dose escalation study of a gentamicin vancomycin gel in patients undergoing colorectal surgeryElliott Bennett-Guerrero, Harold S Minkowitz, Alvaro M Segura-Vasi, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 6, 2007
Correlation between fundamental binding forces and clinical prognosis of Staphylococcus aureus infections of medical implantsRuchirej Yongsunthon, Vance G Fowler, Brian H Lower, et al.
Current Infectious Disease Reports|July 10, 2007
Medical treatment of endocarditisElias Abrutyn, Christopher H Cabell, Vance G Fowler, et al.
Pageof 16